Content Type
Store
Profiles
Forums
Blogs
Events
Frequently Asked Questions
Gallery
Downloads
Glossary
Links Directory
Questions
Jobs
Vendors
Files posted by Cliff
-
Recommendations for the Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly Reactive Screening Tests for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human T-Lymphotropic Virus Type I (HTLV-I)
By Cliff in FDA Memorandum to Blood Establishments
Recommendations for the Quarantine and Disposition of Units from Prior Collections from Donors with Repeatedly Reactive Screening Tests for Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human T-Lymphotropic Virus Type I (HTLV-I)
69 downloads
0 comments
Submitted
-
Human Plasma Collected by Plasmapheresis
By Cliff in Health Canada
Human Plasma Collected by Plasmapheresis
200 downloads
0 comments
Submitted
-
Management of Blood Establishment Submissions
By Cliff in Health Canada
Management of Blood Establishment Submissions
71 downloads
0 comments
Submitted
-
Donor Suitability Related to Laboratory Testing for Viral Hepatitis and a History of Viral Hepatitis
By Cliff in FDA Memorandum to Blood Establishments
Donor Suitability Related to Laboratory Testing for Viral Hepatitis and a History of Viral Hepatitis
83 downloads
0 comments
Submitted
-
Standards for Hospital Transfusion Services
By Cliff in Health Canada
Standards for Hospital Transfusion Services
125 downloads
0 comments
Submitted
-
Memorandum to Licensed Establishments Performing Red Blood Cell Immunizations, Revised Recommendations for Red Blood Cell Immunization Programs for Source Plasma Donors
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Licensed Establishments Performing Red Blood Cell Immunizations, Revised Recommendations for Red Blood Cell Immunization Programs for Source Plasma Donors
67 downloads
0 comments
Submitted
-
Donor Deferral Due to Red Blood Cell Loss During Collection of Source Plasma by Automated Plasmapheresis
By Cliff in FDA Memorandum to Blood Establishments
Donor Deferral Due to Red Blood Cell Loss During Collection of Source Plasma by Automated Plasmapheresis
68 downloads
0 comments
Submitted
-
Memorandum to All Registered Blood Establishments - Recommendations for Donor Screening with a Licensed Test for HIV-1 Antigen
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to All Registered Blood Establishments - Recommendations for Donor Screening with a Licensed Test for HIV-1 Antigen
55 downloads
0 comments
Submitted
-
Reviewer Guidance for a Premarket Notification Submission For Blood Establishment Computer Software
By Cliff in FDA Memorandum to Blood Establishments
Reviewer Guidance for a Premarket Notification Submission For Blood Establishment Computer Software
75 downloads
0 comments
Submitted
-
Memorandum to Registered Blood Establishments - Guidance Regarding Post Donation Information Reports
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood Establishments - Guidance Regarding Post Donation Information Reports
92 downloads
0 comments
Submitted
-
Memorandum to Registered Blood and Plasma Establishments - Additional Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood and Plasma Establishments - Additional Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)
81 downloads
0 comments
Submitted
-
0 comments
Submitted
-
Deferral of Blood and Plasma Donors Based on Medications
By Cliff in FDA Memorandum to Blood Establishments
Deferral of Blood and Plasma Donors Based on Medications
79 downloads
0 comments
Submitted
-
Clarification of the Use of Unlicensed Anti-HCV Supplemental Test Results in Regard to Donor Notification
By Cliff in FDA Memorandum to Blood Establishments
Clarification of the Use of Unlicensed Anti-HCV Supplemental Test Results in Regard to Donor Notification
93 downloads
0 comments
Submitted
-
Stakeholder Consultation on the Proposed Regulatory Framework for Blood and Blood Components - Consultation Report
By Cliff in Health Canada
Stakeholder Consultation on the Proposed Regulatory Framework for Blood and Blood Components - Consultation Report
58 downloads
0 comments
Submitted
-
Adequate and Appropriate Donor Screening Tests for Hepatitis B; Hepatitis B Surface Antigen (HBsAg) Assays Used to Test Donors of Whole Blood and Blood Components, Including Source Plasma and Source Leukocytes
By Cliff in FDA Blood Guidances
Docket Number: 2002D-0081 Issued by: Center for Biologics Evaluation and Research Blood establishments are required under 21 CFR 610.40(a)(3) and (b) to test donations of human blood and blood components for hepatitis B virus using approved screening tests that are adequate and appropriate for this purpose. One test used to detect the presence of hepatitis B infection is the hepatitis B surface antigen (HBsAg) test.
0 downloads
0 comments
Submitted
-
Memorandum to Registered Blood Establishments - Use of an FDA Cleared or Approved Sterile Connecting Device (STCD) in Blood Bank Practices
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood Establishments - Use of an FDA Cleared or Approved Sterile Connecting Device (STCD) in Blood Bank Practices
98 downloads
0 comments
Submitted
-
Volume Limits for Automated Collection of Source Plasma
By Cliff in FDA Memorandum to Blood Establishments
Volume Limits for Automated Collection of Source Plasma
73 downloads
0 comments
Submitted
-
Revised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)
By Cliff in FDA Memorandum to Blood Establishments
Revised Recommendations for Testing Whole Blood, Blood Components, Source Plasma and Source Leukocytes for Antibody to Hepatitis C Virus Encoded Antigen (Anti-HCV)
85 downloads
0 comments
Submitted
-
Revised Recommendations for the Prevention of Human Immunodeficiency Virus (HIV) Transmission by Blood and Blood Products
By Cliff in FDA Memorandum to Blood Establishments
Revised Recommendations for the Prevention of Human Immunodeficiency Virus (HIV) Transmission by Blood and Blood Products
167 downloads
0 comments
Submitted
-
Memorandum to Registered Blood Establishments- Recommendations for Deferral of Donors for Malaria Risk
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood Establishments- Recommendations for Deferral of Donors for Malaria Risk
90 downloads
0 comments
Submitted
-
Software Used in Blood Establishments
By Cliff in FDA Memorandum to Blood Establishments
Software Used in Blood Establishments
60 downloads
0 comments
Submitted
-
Memorandum to Registered Blood Establishments, Timeframe for Licensing Irradiated Blood Products
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood Establishments, Timeframe for Licensing Irradiated Blood Products
65 downloads
0 comments
Submitted
-
Memorandum to Registered Blood Establishments, Recommendations to Users of Medical Devices That Test for Infectious Disease Markers by Enzyme Immunoassay (EIA) Test Systems
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood Establishments, Recommendations to Users of Medical Devices That Test for Infectious Disease Markers by Enzyme Immunoassay (EIA) Test Systems
68 downloads
0 comments
Submitted
-
Memorandum to Registered Blood and Source Plasma Establishments, Revision of FDA Memorandum of August 27,1982: Requirements for Infrequent Plasmapheresis Donors
By Cliff in FDA Memorandum to Blood Establishments
Memorandum to Registered Blood and Source Plasma Establishments, Revision of FDA Memorandum of August 27,1982: Requirements for Infrequent Plasmapheresis Donors
56 downloads
0 comments
Submitted